MétaCan
← all works

A decade of clinical development of PARP inhibitors in perspective

2019· review· en· 730 citations· W2951058429 on OpenAlex· 10.1093/annonc/mdz192

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.

Abstract

No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.

The record

Venue
Annals of Oncology
Topic
PARP inhibition in cancer therapy
Field
Medicine
Canadian institutions
Funders
Fundación FeroInstitute of Cancer ResearchProstate Cancer FoundationCancer Research UKNational Institute on Handicapped ResearchDepartment of Health and Aged Care, Australian GovernmentInstituto de Salud Carlos IIINational Institute for Health and Care Research
Keywords
MedicinePerspective (graphical)Intensive care medicineMedical physicsArtificial intelligence
Has abstract in OpenAlex
no